Godavari Biorefineries Share Price Hits 10% Upper Circuit on European Patent Approval

Godavari Biorefineries share price (NSE: GODAVARIB) surged to the upper circuit limit of 10%, reaching ₹263 per share on NSE and ₹263.45 on BSE on October 16, 2025. Around 0.22 million shares worth ₹5.52 crore were traded before the halt in trading.

European Patent Sparks Rally

The stock rallied after the company announced that its patent application for compounds from its Anti-Cancer Research Segment has been approved in Europe. The patented compounds are designed to inhibit unregulated cell growth, particularly targeting cancer stem cells, with potential applications in treating cancers such as breast and prostate cancer.

Godavari Biorefineries Share Price History

Godavari Biorefineries went public on October 30 last year, raising ₹554.75 crore through its IPO. The IPO price was ₹352 per share, while shares listed at ₹310.55 on BSE and ₹308 on NSE. Despite being below the IPO and listing price, the stock has gained 61% year-to-date, recovering from an initial post-listing dip.

Also Read: RBI Unveils Retail Digital Currency Sandbox!

Conclusion

The approval of the European patent marks a significant milestone for Godavari Biorefineries’ anti-cancer research and has fueled strong investor interest, pushing shares to their upper circuit.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a pe₹onal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.